WednesdayNov 03, 2021 1:54 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Slated for Live Broadcast from VirtualInvestorConferences.com

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer hearing-health technology space, has announced that company president and CEO Matthew Moore will be presenting live at the upcoming VirtualInvestorConferences.com. The event is scheduled for Nov. 4, and Moore’s real-time webcast is scheduled to begin at 4 p.m. EST. Individual and institutional investors, advisors and analysts are invited to participate in the interactive presentation, which will include time for questions and answers; preregistration is encouraged. An archived copy of the presentation will be available for viewing after the event. To view the webcast, visit https://ibn.fm/boYyg   To view…

Continue Reading

WednesdayNov 03, 2021 1:39 pm

QualityStocksNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Plans to Launch VapeTV US

Marijuana Company of America (OTC: MCOA), a diversified holding company with operations and investments throughout the cannabis industry, today announced its entry into a non-binding letter of intent (“LOI”) for the formation of a new in-store advertising business to be called VapeTV US Inc. According to the update, MCOA's wholly owned distribution company, cDistro Inc., will own 25% of the VapeTV US business, partnering with VapeTV Ltd. of the United Kingdom and Jasleen Enterprises LLC, the owner of Vapor Maven. “We are excited to initiate the U.S. market version of the highly successful and lucrative VapeTV business,” said Mike Shaw,…

Continue Reading

WednesdayNov 03, 2021 1:35 pm

The Cannabis World Congress & Business Exposition (CWCBExpo) Is Set to Headline the New York Cannabis Week; Will Bring Together Hundreds of Businesses from Across the Cannabis Ecosystem

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held in New York between November 4-6, 2021 The conference will feature over 50 expert speakers, in addition to hundreds of exhibitors showcasing the sector’s latest product innovations Recent forecasts have estimated overall US marijuana retail sales to rise from $20 billion in 2020 to $38.4-45.9 billion by 2025 The Cannabis World Congress & Business Exposition (“CWCBExpo”) event is set to be held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021. Set to be held during Cannabis Week, a weeklong event taking place between Monday…

Continue Reading

WednesdayNov 03, 2021 1:20 pm

FingerMotion Inc. (FNGR) Adding More Value to Core Communications Services with Mobile Device Protection Brands

U.S.-based FingerMotion is a communications technology services company focused on the enormous Chinese consumer base and its adoption of mobile devices FingerMotion has established its operations on a stable tripod of services including SMS, MMS, and big data technologies The company recently reported growing revenues derived primarily from its SMS and MMS products  On Oct. 25 the company introduced two new brands for value-added services that will help underwrite protection plans for mobile devices during the coming year FingerMotion expects its big data platform Sapientus to eventually outstrip SMS and MMS revenues as it becomes a significant tool for establishing…

Continue Reading

WednesdayNov 03, 2021 12:50 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Strategic Engagement of MZ Group

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) today announced its engagement of international investor relations specialists MZ Group to lead a comprehensive strategic investor relations and financial communications program across all key markets. The partnership with MZ represents an investment in BevCanna’s go-forward growth strategy as the company rapidly accelerates its evolution into a diversified health and wellness company. “Cannabis is an emerging leader within the overall $4.5 trillion wellness market, with the product market projected to reach $90.4 billion by 2026, according to MarketsandMarkets,” said Ted Haberfield, chairman and president of MZ Group North America. “BevCanna leverages proprietary…

Continue Reading

WednesdayNov 03, 2021 12:42 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) Announces Upsizing of Non-Brokered Private Placement

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR), a propriety software as a service (“SaaS”) technology company delivering mobile live dealer technology to online gaming operators globally, today announced that, further to its Oct. 28 news release, it intends to upsize its previously announced non-brokered private placement (the “proposed offering”) of units of the company. According to the update, the upsized proposed offering is expected to be for gross proceeds of up to $9,000,000 through the sale of up to 30,000,000 units, each at a price of $0.30. Each unit will be comprised of one common share of the company…

Continue Reading

WednesdayNov 03, 2021 12:27 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology’s Efficacy in Reducing/Inhibiting Seizure Activity; Strengthens IP Portfolio

Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, Epidiolex The study will also compare DehydraTECH-CBD to generic CBD EPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022 Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted patents Lexaria Bioscience (NASDAQ: LEXX), the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology, recently announced it had commenced an important new animal study, EPIL-A21-1 (https://ibn.fm/LG7O6). EPIL-A21-1, which will be…

Continue Reading

WednesdayNov 03, 2021 12:11 pm

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Releases Financial, Operations Report

ISW Holdings (OTC: ISWH), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining that is in the process of changing its name to BlockQuarry, has reported key financial date for the three and nine months ended Sept. 30, 2021. Highlights for the period include revenues from operations for the three-month period totaling $1.075 million including deferred revenues, which is a 2,435% increase on a year-over-year basis, and net revenues excluding deferred revenues for the same period grew 579%. Net revenues excluding deferred revenues for the nine-month period grew 185% on a year-over-year basis, with the reported net cash…

Continue Reading

WednesdayNov 03, 2021 11:41 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Expand Hypertension Clinical Program Through Most Ambitious Study to Date

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced a significant new study to expand its hypertension clinical program. In addition, the company provided updates on three ongoing human clinical studies evaluating its proprietary DehydraTECH-CBD for potentially treating hypertension and heart disease. “HYPER-H21-4 is the most ambitious study Lexaria has ever undertaken and is enabled from the successful outcomes from our other 2021 human hypertension studies,” said Lexaria CEO Chris Bunka in the news release. “Outcomes from this study could support Lexaria's goals related to pursuit of regulatory approvals for DehydraTECH-CBD for potential use as…

Continue Reading

WednesdayNov 03, 2021 11:12 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids, today announced its filing of an international patent application demonstrating neuroprotection and enhanced neuronal function using a rare cannabinoid for the potential treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s and others. The Patent Cooperation Treaty (“PCT”) application, entitled “Compositions and Methods for Treating Neuronal Disorders with Cannabinoids,” specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative diseases by providing neuroprotection in a population of affected neurons. Further, the PCT application demonstrates the subject cannabinoid compound can also be used…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered